NCT05005078View on ClinicalTrials.gov

A 16-Week Study of Pirenzepine or Placebo to Treat HIV-Associated Distal Sensory Polyneuropathy in Patients With HIV

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 24, 2022

Primary Completion Date

January 18, 2023

Study Completion Date

January 24, 2023

Conditions
HIV Associated Polyneuropathy
Interventions
DRUG

WST-057

WST-057 topical solution

DRUG

Placebo

WST-057 Matching placebo

Trial Locations (2)

92103

University of California San Diego, San Diego

92262

Palmtree Clinical Research, Palm Springs

All Listed Sponsors
lead

WinSanTor, Inc

INDUSTRY